QRG Capital Management Inc. Sells 8,127 Shares of Teladoc Health, Inc. (NYSE:TDOC)

QRG Capital Management Inc. reduced its stake in Teladoc Health, Inc. (NYSE:TDOC) by 32.0% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 17,268 shares of the health services provider’s stock after selling 8,127 shares during the quarter. QRG Capital Management Inc.’s holdings in Teladoc Health were worth $159,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently bought and sold shares of TDOC. Signaturefd LLC lifted its position in shares of Teladoc Health by 148.7% during the 2nd quarter. Signaturefd LLC now owns 2,868 shares of the health services provider’s stock valued at $28,000 after buying an additional 1,715 shares in the last quarter. International Assets Investment Management LLC purchased a new position in Teladoc Health during the second quarter valued at approximately $29,000. Blue Trust Inc. boosted its position in shares of Teladoc Health by 84.5% in the third quarter. Blue Trust Inc. now owns 4,048 shares of the health services provider’s stock worth $40,000 after purchasing an additional 1,854 shares during the period. Doheny Asset Management CA purchased a new stake in shares of Teladoc Health in the second quarter worth $46,000. Finally, SageView Advisory Group LLC bought a new stake in shares of Teladoc Health during the 1st quarter valued at $48,000. 76.82% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, CFO Mala Murthy sold 8,750 shares of the company’s stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $7.16, for a total transaction of $62,650.00. Following the transaction, the chief financial officer now owns 85,767 shares of the company’s stock, valued at approximately $614,091.72. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. In other news, CFO Mala Murthy sold 8,750 shares of the company’s stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $7.16, for a total value of $62,650.00. Following the transaction, the chief financial officer now directly owns 85,767 shares in the company, valued at approximately $614,091.72. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Thomas Mckinley purchased 4,000 shares of Teladoc Health stock in a transaction that occurred on Thursday, September 12th. The stock was bought at an average cost of $7.69 per share, for a total transaction of $30,760.00. Following the purchase, the director now directly owns 39,077 shares in the company, valued at $300,502.13. This trade represents a 0.00 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have sold 20,051 shares of company stock valued at $143,565 in the last ninety days. 0.95% of the stock is owned by company insiders.

Analysts Set New Price Targets

Several brokerages recently weighed in on TDOC. DA Davidson dropped their target price on shares of Teladoc Health from $12.00 to $8.00 and set a “neutral” rating for the company in a report on Thursday, August 1st. Stifel Nicolaus cut their target price on Teladoc Health from $16.00 to $9.00 and set a “hold” rating for the company in a research report on Thursday, August 1st. Oppenheimer lowered their price target on Teladoc Health from $21.00 to $17.00 and set an “outperform” rating on the stock in a report on Thursday, August 1st. Deutsche Bank Aktiengesellschaft increased their price objective on shares of Teladoc Health from $10.00 to $12.00 and gave the company a “hold” rating in a report on Friday, November 1st. Finally, Canaccord Genuity Group lowered their target price on shares of Teladoc Health from $25.00 to $17.00 and set a “buy” rating on the stock in a report on Thursday, August 1st. Fourteen analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $11.97.

Teladoc Health Stock Performance

NYSE TDOC opened at $9.71 on Wednesday. The business’s 50 day moving average price is $8.79 and its 200-day moving average price is $9.44. Teladoc Health, Inc. has a fifty-two week low of $6.76 and a fifty-two week high of $22.54. The company has a market cap of $1.67 billion, a P/E ratio of -1.68 and a beta of 0.90. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73.

Teladoc Health (NYSE:TDOC) last posted its quarterly earnings data on Wednesday, October 30th. The health services provider reported ($0.19) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.10. The business had revenue of $640.51 million for the quarter, compared to analysts’ expectations of $630.50 million. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. Sell-side analysts predict that Teladoc Health, Inc. will post -1.19 earnings per share for the current year.

Teladoc Health Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.